Date: June 25, 2024 By: Zach Winn
This study, published in Immunity on August 30, used a non-human primate model to demonstrate that previous Mtb infection leads to a durable, protective immune response that is dependent on CD4+ T cells.
MIT researchers find that the first dose primes the immune system, helping it to generate a strong response to the second dose, a week later.
We are deeply saddened to announce the passing of Ragon Institute faculty member Todd M. Allen, PhD, a pioneering researcher in T cell immunotherapy and HIV evolution and transmission.
